Skip to main content

Publisher: Wiley-Blackwell

Volume 7, Supplement 1, May/June 1997

Introduction
pp. 1-3(3)
Author: GUASTALLA, J. P.

Favourites:
ADD

Prognostic factors in advanced ovarian cancer
pp. 4-8(5)
Author: CERVANTES, A.

Favourites:
ADD

Combination paclitaxel (Taxol®)–cisplatin vs cyclophosphamide–cisplatin as primary therapy in patients with suboptimally debulked advanced ovarian cancer
pp. 9-13(5)
Authors: HOSKINS, W. J.; MCGUIRE, W. P.; BRADY, M. F.; KUCERA, P. R.; PARTRIDGE, E. E.; LOOK, K. Y.; CLARKE-PEARSON, D. L.; DAVIDSON, M.

Favourites:
ADD

Ovarian cancer in elderly women
pp. 23-26(4)
Authors: CONTE, P.- F.; ROMANINI, A.; BRUNETTI, I.; GIANNESSI, P.; FANUCCHI, A.; GADDUCCI, A.

Favourites:
ADD

Controversies in the management of ovarian cancer
pp. 27-32(6)
Author: OZOLS, R. F.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more